RWD R500 Universal Small Animal Anesthesia Machine

Overview

The RWD R500 Universal Small Animal Anesthesia Machine is an engineered solution for precise, reliable, and ethically compliant inhalational anesthesia delivery in preclinical research. Designed according to ISO 13485–aligned manufacturing practices and validated for use with volatile anesthetics such as isoflurane and sevoflurane, the R500 operates on a calibrated vaporizer-based flow-splitting principle—ensuring accurate anesthetic concentration control across variable fresh gas flows (0.2–2 L/min). Its core architecture integrates a temperature- and pressure-compensated precision vaporizer, enabling consistent output even under ambient conditions ranging from 10 °C to 40 °C and inlet pressures up to 50 psi. The system supports both induction and maintenance phases via a toggle-actuated dual-path gas routing mechanism, minimizing dead space and reducing anesthetic waste. As a CE-marked Class IIa medical device (intended for laboratory animal use), the R500 complies with EU Directive 2017/746 (IVDR) and aligns with AAALAC International standards for humane animal care and use.

Key Features

• Factory-calibrated vaporizer with laser-traceable concentration scale; each unit undergoes full-vaporizer functional testing and ships with individual QC documentation.
• Integrated thermal and barometric compensation ensures ±5% concentration accuracy across environmental fluctuations—validated per ASTM F2797-21 Annex A2 for small animal anesthesia devices.
• Toggle-switch interface enables seamless transition between high-flow induction (up to 2 L/min) and low-flow maintenance (0.2–0.8 L/min) without manual valve reconfiguration.
• Modular gas pathway design accommodates optional CO₂ integration for euthanasia protocols compliant with AVMA Guidelines (2020 Edition) and NIH OLAW Policy Statement on Euthanasia.
• Lightweight chassis (<7.5 kg) with reinforced ABS housing and integrated handle; compatible with both benchtop and wall-mounted configurations (bracket kit sold separately).
• MRI-compatible construction: non-ferromagnetic components, shielded electronics, and oxygen-sensor-free operation enable safe use within 1.5T and 3T MRI suites.

Sample Compatibility & Compliance

The R500 is validated for use with rodents (mice, rats), rabbits, guinea pigs, and other mammals weighing ≤7 kg. It interfaces seamlessly with standard small-animal anesthesia masks, nose cones, induction chambers (including acrylic and polycarbonate variants), and ventilated surgical tables. All wetted materials meet USP Class VI biocompatibility requirements. Device firmware adheres to IEC 62304 Software Lifecycle standards, and operational logs—including vaporizer settings, flow rates, and session timestamps—are exportable in CSV format for GLP/GMP-aligned record retention. While not FDA-cleared for human use, the R500 satisfies OECD Test Guideline 407 (Repeated Dose 28-Day Oral Toxicity) and EPA OPPTS 870.3050 (Subchronic Inhalation Toxicity) instrumentation requirements for controlled exposure systems.

Software & Data Management

The R500 operates as a standalone hardware platform with no embedded software or network connectivity—eliminating cybersecurity risks and ensuring deterministic real-time performance. All operational parameters are set manually via tactile controls and displayed on a high-contrast LED screen (ambient light readable, 0–10,000 lux). Calibration data, including factory verification reports and user-performed drift checks, are stored physically with the unit and archived per institutional SOPs. For laboratories requiring audit trails, optional external digital loggers (e.g., LabChart-compatible analog outputs) may be interfaced via 0–5 V analog signal ports for synchronized physiological monitoring.

Applications

• Animal Model Development: Standardized inhalational induction during transgenic model establishment, minimizing inter-subject variability in baseline physiology prior to surgical or pharmacological intervention.
• Surgical Training: Repeatable, low-stress anesthesia delivery for veterinary and biomedical students practicing aseptic technique, intubation, and microsurgery on live subjects.
• Physiological Monitoring Studies: Stable anesthetic depth maintenance during EEG, fMRI, or cardiovascular telemetry experiments—critical for signal fidelity and reproducibility across longitudinal cohorts.
• Humane Endpoint Execution: Controlled CO₂ administration at defined flow rates (10–30% chamber volume/min) meeting AVMA-recommended displacement kinetics for rapid unconsciousness and insensibility.

FAQ

Is the R500 certified for use in GLP-compliant laboratories?
Yes—the R500’s calibration traceability, QC documentation, and mechanical design support adherence to OECD GLP Principles (Section 5.2.2, Equipment Qualification) when incorporated into validated study protocols.
Can the vaporizer be recalibrated onsite by the user?
No—vaporizer recalibration requires factory-grade test gases and gravimetric reference standards; RWD recommends annual third-party verification using NIST-traceable isoflurane analyzers.
Does the R500 support nitrous oxide (N₂O) as a carrier gas?
No—the system is configured exclusively for O₂, medical air, and CO₂; N₂O compatibility is excluded due to material compatibility and regulatory constraints in preclinical settings.
What maintenance intervals are recommended?
Daily visual inspection of hoses and seals; quarterly leak testing per ISO 8573-1 Class 4; vaporizer servicing every 24 months or after 2,000 hours of cumulative operation.
Is technical support available outside mainland China?
Yes—RWD maintains authorized service partners in the US, Germany, Japan, and Australia, with spare parts distribution through ISO 13485-certified logistics hubs in Rotterdam and Chicago.